Hepatocellular Carcinoma Surveillance Following Hepatitis C Virus Cure.
作者信息
Kwo Paul Y
机构信息
Professor of Medicine Director of Hepatology Division of Gastroenterology and Hepatology Stanford University Medical School Stanford, California.
出版信息
Gastroenterol Hepatol (N Y). 2025 Jan;21(1):72-74.
Abstract
摘要
相似文献
1
Hepatocellular Carcinoma Surveillance Following Hepatitis C Virus Cure.丙型肝炎病毒治愈后的肝细胞癌监测
Gastroenterol Hepatol (N Y). 2025 Jan;21(1):72-74.
2
Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival.丙型肝炎病毒治愈前诊断为肝细胞癌与改善生存相关。
J Viral Hepat. 2021 May;28(5):710-718. doi: 10.1111/jvh.13475. Epub 2021 Feb 2.
3
Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model.乙型肝炎病毒相关肝细胞癌肝切除术后的统计学治愈：一种风险分层模型。
Ann Surg Oncol. 2025 Jun;32(6):4396-4407. doi: 10.1245/s10434-025-17176-1. Epub 2025 Apr 5.
4
A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression.丙型肝炎病毒治愈的弊端？需要警惕乙型肝炎病毒再激活、器官排斥或肝细胞癌进展。
J Infect Dis. 2018 Mar 5;217(6):857-860. doi: 10.1093/infdis/jix659.
5
Risk of hepatocellular carcinoma after hepatitis C virus cure.丙型肝炎病毒治愈后肝细胞癌的风险。
World J Gastroenterol. 2022 Jan 7;28(1):96-107. doi: 10.3748/wjg.v28.i1.96.
6
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals.丙型肝炎病毒治愈个体中用于监测的肝细胞癌发病率阈值。
Clin Gastroenterol Hepatol. 2024 Jan;22(1):91-101.e6. doi: 10.1016/j.cgh.2023.05.024. Epub 2023 Jun 9.
7
[Screening and surveillance for hepatocellular carcinoma in patients with chronic hepatitis B virus infection].[慢性乙型肝炎病毒感染患者肝细胞癌的筛查与监测]
Zhonghua Gan Zang Bing Za Zhi. 2021 Oct 20;29(10):932-941. doi: 10.3760/cma.j.cn501113-20210927-00484.
8
Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.乙型肝炎病毒相关肝癌风险人群和接受抗病毒治疗人群的肝癌筛查应用。
J Clin Nurs. 2018 Jul;27(13-14):2673-2683. doi: 10.1111/jocn.14367. Epub 2018 May 28.
9
Hepatocellular carcinoma surveillance, incidence, and tumor doubling times in patients cured of hepatitis C.丙型肝炎治愈患者的肝细胞癌监测、发病率和肿瘤倍增时间。
Cancer Med. 2022 May;11(9):1995-2005. doi: 10.1002/cam4.4508. Epub 2022 Mar 9.
10
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals.直接抗病毒药物清除丙型肝炎病毒后的长期肝脏发病率和死亡率
J Gastroenterol Hepatol. 2025 Apr;40(4):971-978. doi: 10.1111/jgh.16892. Epub 2025 Feb 2.
本文引用的文献
1
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.慢性丙型肝炎治愈后伴晚期纤维化或肝硬化患者的 HCC 发病率：一项荟萃分析。
Hepatology. 2022 Jul;76(1):139-154. doi: 10.1002/hep.32341. Epub 2022 Feb 7.
2
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.丙型肝炎病毒感染和高级纤维化患者治疗后持续病毒学应答的肝细胞癌监测的成本效益。
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1840-1849.e16. doi: 10.1016/j.cgh.2018.12.018. Epub 2018 Dec 20.
3
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
4
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.直接作用抗病毒 HCV 治疗后肝细胞癌风险：系统评价、荟萃分析和荟萃回归。
J Hepatol. 2017 Dec;67(6):1204-1212. doi: 10.1016/j.jhep.2017.07.025. Epub 2017 Aug 9.
5
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.直接作用抗病毒药物治疗的 HCV 患者的肝细胞癌风险。
Gastroenterology. 2017 Oct;153(4):996-1005.e1. doi: 10.1053/j.gastro.2017.06.012. Epub 2017 Jun 19.
Zotero 插件